Devyser today announced that it entered a strategic agreement with Illumina, a global leader in DNA sequencing and array-based technologies, to provide Illumina sequencing instruments and related prod ...
Government-backed population genomics projects escalate demand, while AI and long-read sequencing tech enhance data analysis ...
Illumina has unveiled a database of genomic alterations, called the Billion Cell Atlas, that can be used to identify and ...
The market for whole genome and exome sequencing is set to grow significantly, driven by decreasing sequencing costs and a ...
Looking to usher in a more “predictable” year in 2026, Illumina is working with officials in China as it remains on the ...
Illumina, a San Diego-based genome sequencing provider, signed a long-term lease for a 316,000-square-foot complex less than one mile from its headquarters, The San Diego Union-Tribune reports.
Jan 13 (Reuters) - Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help ...
Researchers are now exploring how to best extract and use saliva-derived DNA for long-read sequencing applications. Download ...
Illumina shares edge down 3.5% in premarket trading after China placed restrictions on the company as it caught itself in the country's crosshairs in response to a developing trade war. Shares were ...
We recently compiled a list of the Top 10 Oncology Stocks to Buy Now. Illumina Inc. is another one of the best cancer stocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results